Purchase Order 75N93018P00885

This firm fixed-price purchase order for $18,204.88 was awarded by the Department of Health and Human Services' National Institutes of Health National Institute on Drug Abuse to Genscript USA Inc. to obtain cell lines utilizing CRISPR gene editing technology. Specifically, the contract calls for Genscript to generate knockout HEK293 and HepG2 cell lines of the MMAB and MUT genes to support studies for hereditary disorders of vitamin B12 and methylmalonic acid metabolism. No set-aside designation...

This firm fixed-price purchase order awarded by the National Institutes of Health's National Center for Advancing Translational Sciences to Active Motif, Inc. is valued at $405,000. Under the terms of the contract, Active Motif will provide single-nuclei multiome analysis services for 50 samples of human brain tissue, induced pluripotent stem cell-derived cells, or human dorsal root ganglion as requested in Solicitation Number NCATS-23-0414. The solicitation sought these sequencing and data...

The Department of Health and Human Services National Institutes of Health National Institute of Environmental Health Sciences awarded a $309,750 firm fixed price purchase order to Active Motif, Inc. for FactorPath ChIP-Seq, HistonePath and input sequencing services. The solicitation sought these epigenetic profiling services to characterize patient-derived dermal fibroblasts and determine the impact of ancestry, sex, and age on induced pluripotent stem cell reprogramming efficiency. Active Motif...

Springer Nature Customer Service Center LLC has been awarded a $11,690 firm fixed price purchase order by the National Institutes of Health's National Institute of Neurological Disorders and Stroke to provide manuscript publication fees for deep phenotyping research relating to myalgic encephalomyelitis/chronic fatigue syndrome. The work will be performed in Bowling Green, New York over a one year period ending August 2024. No set aside designation or involvement of major subcontractors was...

This firm fixed-price purchase order awarded by the U.S. Army Medical Command (MEDCOM) to Ajinomoto Althea, Inc. is for stability testing of Hantaan and Puumala deoxyribonucleic acid (DNA) plasmids, in support of research conducted by the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID). The contract has a ceiling value of $26,700.00 and a period of performance through September 23, 2024. The contract was awarded on a sole-source basis, as Ajinomoto Althea is currently...

This purchase order, awarded by the National Institutes of Health's National Institute of Child Health and Human Development, is for one unit of HAPLOGEN HAP1DEPDC52039600 CRISPR/CAS9-EDITED DEPDC5 for $1,105.90, with a total contract value of $5,728.50. The prime contractor, Government Scientific Source Inc. doing business as G S S, will deliver the product from its place of performance in Herndon, Virginia between September 11, 2014 and October 31, 2014 under firm fixed pricing. No set aside...

The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a $24,035 firm fixed price purchase order to Medchemexpress LLC of Princeton, New Jersey. The order is for photoredox chemistry discovery services with a completion date of November 4, 2022. No set-aside designation was used for this award to support the National Center's programs in translational sciences. The potential value matches the award amount to...

The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a Firm Fixed Price Purchase Order to GenScript USA Inc., a for-profit biotechnology company, to provide DETECTION OF MUTATION-REACTIVE T CELLS IN PATIENTS WITH METASTATIC CANCERS. The contract has a potential value of $849,989.66 and a completion date of September 21, 2019. The contract does not have a set-aside designation. GenScript USA Inc. has a history of providing customized DNA,...

This is a $1,094,682.00 Firm Fixed Price contract awarded by the U.S. Army Medical Command (MEDCOM) to Epigen Biosciences Inc., a small business based in San Diego, California. The contract is for the research and development of small molecule compounds, with a focus on potential therapeutic applications in areas such as stroke, liver diseases, neurodegenerative disorders, and neuropathic conditions. Epigen Biosciences has received prior grant funding from various National Institutes of Health...

The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm-fixed-price purchase order to Genscript USA Inc., a biotechnology company, for "EXPRESS PLASMID PREPARATION, EXPRESS MUTAGENESIS TARGET AND CLONEARK PLASMID PREPARATION" services. The $149,984.10 contract has a completion date of September 13, 2022 and does not have a set-aside designation. Genscript has provided similar services to support...